Cardiovascular Systems to Webcast Fiscal 2010 Second-Quarter Earnings Conference Call Wednesday, February 3
January 27 2010 - 6:03PM
Business Wire
Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII) will host a
live webcast of its fiscal 2010 second-quarter conference call on
Wednesday, February 3, 2010, at 3:45 p.m. CT (4:45 p.m. ET). David
L. Martin, president and chief executive officer, and Laurence L.
Betterley, chief financial officer, will discuss the company’s
results for its fiscal second quarter ended December 31, 2009, and
its financial outlook. The company will issue a post-market
earnings release on February 3.
To access the live webcast, go to the investor information
section of the company’s Web site, www.csi360.com, on the day of the
conference call and click on the webcast icon. A webcast replay
will be available beginning at 7 p.m. CT the same day.
To participate in the conference call, dial (888) 680-0879 and
enter 66378363. Please dial in at least 10 minutes prior to the
call. To pre-register for the call, log on to the following Web
site:
https://www.theconferencingservice.com/prereg/key.process?key=PT36GRUXE.
When joining the call, pre-registered participants can enter their
PIN code, and other participants can wait for operator
assistance.
If you do not have access to the Internet and want to listen to
an audio replay of the conference call, dial (888) 286-8010 and
enter access number 41659872. The audio replay will be available
beginning at 8 p.m. CT on Wednesday, February 3, 2010, through 6
p.m. CT on Friday, February 5, 2010.
Cardiovascular Systems, Inc., based in St. Paul, Minn., is a
medical device company focused on developing and commercializing
interventional treatment systems for vascular disease. The
company’s Diamondback 360® PAD System treats calcified and fibrotic
plaque in arterial vessels throughout the leg in a few minutes of
treatment time, and addresses many of the limitations associated
with existing surgical, catheter and pharmacological treatment
alternatives. As many as 12 million Americans suffer from
peripheral arterial disease (PAD), which is caused by the
accumulation of plaque in peripheral arteries (commonly the pelvis
or leg) reducing blood flow. Symptoms include leg pain when walking
or at rest, and can lead to tissue loss and eventually limb
amputation. In August 2007, the U.S. FDA granted 510(k) clearance
for the use of the Diamondback 360° as a therapy for PAD, and CSI
commenced a U.S. product launch in September 2007. Since then, more
than 20,000 procedures have been performed to-date using the
Diamondback 360° in leading institutions across the United States.
For more information visit the company’s Web site at
www.csi360.com.
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From May 2024 to Jun 2024
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Jun 2023 to Jun 2024